UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
NCT ID: NCT02978391
Last Updated: 2022-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2016-05-23
2017-09-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Posttraumatic Swelling and Pain With Zhi Kang Capsule
NCT03363971
Tracking Wound Infection With Smartphone Technology
NCT02704897
EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
NCT05130814
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
NCT02154087
Research to Evaluate Efficiency in U-health Solution Service for the Chronic Wound Management
NCT02382302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UI-EWD Hemostatic system
Patients with upper gastrointestinal bleeding treated with UI-EWD
UI-EWD Hemostatic system
Adhesive endoscopic hemostats, powder type
epinephrine
Patients with upper gastrointestinal bleeding treated with submucosal epinephrine injection
epinephrine endoscopic injection (conventional therapy)
endoscopic submucosal injection of epinephrine (1: 10,000)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UI-EWD Hemostatic system
Adhesive endoscopic hemostats, powder type
epinephrine endoscopic injection (conventional therapy)
endoscopic submucosal injection of epinephrine (1: 10,000)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Connot stop taking the antiplatelet drug, NSAID, Anticoagulant drug, and Aspirin during endoscopic treatment and after 72h endoscopy
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Next Biomedical Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yong-Woon Shin
Role: PRINCIPAL_INVESTIGATOR
Inha University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soonchunhyang University College of Medicine
Bucheon-si, , South Korea
Inha University Hospital
Incheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEXTBIO-631-EWD3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.